The University of Chicago Header Logo

Connection

Rajat Thawani to Bevacizumab

Back to Details
This is a "connection" page, showing publications Rajat Thawani has written about Bevacizumab.
Rajat Thawani
Connection Strength
0.052
Bevacizumab
  1. Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta-analysis. Cancer Med. 2023 12; 12(24):21579-21591.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.